Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDIA GLYCOLS vs STERLING BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDIA GLYCOLS STERLING BIOTECH INDIA GLYCOLS/
STERLING BIOTECH
 
P/E (TTM) x 21.6 -0.0 - View Chart
P/BV x 1.7 0.1 2,251.5% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 INDIA GLYCOLS   STERLING BIOTECH
EQUITY SHARE DATA
    INDIA GLYCOLS
Mar-24
STERLING BIOTECH
Mar-18
INDIA GLYCOLS/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs9797 14,459.4%   
Low Rs5142 31,341.5%   
Sales per share (Unadj.) Rs-430.812.7 -3,398.8%  
Earnings per share (Unadj.) Rs55.9-36.9 -151.3%  
Cash flow per share (Unadj.) Rs88.4-27.9 -316.8%  
Dividends per share (Unadj.) Rs8.000-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs662.510.1 6,536.3%  
Shares outstanding (eoy) m30.96272.17 11.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x-1.70.3 -522.3%   
Avg P/E ratio x13.4-0.1 -11,736.0%  
P/CF ratio (eoy) x8.4-0.2 -5,603.4%  
Price / Book Value ratio x1.10.4 271.6%  
Dividend payout %14.30-   
Avg Mkt Cap Rs m23,1111,144 2,019.4%   
No. of employees `000NANA-   
Total wages/salary Rs m1,034583 177.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m-13,3363,449 -386.6%  
Other income Rs m28555 518.9%   
Total revenues Rs m-13,0513,504 -372.4%   
Gross profit Rs m4,190-7,582 -55.3%  
Depreciation Rs m1,0082,457 41.0%   
Interest Rs m1,2354,397 28.1%   
Profit before tax Rs m2,233-14,381 -15.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m503-4,327 -11.6%   
Profit after tax Rs m1,730-10,054 -17.2%  
Gross profit margin %-31.4-219.8 14.3%  
Effective tax rate %22.530.1 74.9%   
Net profit margin %-13.0-291.5 4.5%  
BALANCE SHEET DATA
Current assets Rs m19,4474,807 404.6%   
Current liabilities Rs m23,74756,226 42.2%   
Net working cap to sales %32.2-1,490.7 -2.2%  
Current ratio x0.80.1 957.9%  
Inventory Days Days-1051,685 -6.2%  
Debtors Days Days-1,051543 -193.5%  
Net fixed assets Rs m36,72165,836 55.8%   
Share capital Rs m310272 113.8%   
"Free" reserves Rs m20,2012,486 812.5%   
Net worth Rs m20,5102,759 743.5%   
Long term debt Rs m7,25119,787 36.6%   
Total assets Rs m56,16870,643 79.5%  
Interest coverage x2.8-2.3 -123.7%   
Debt to equity ratio x0.47.2 4.9%  
Sales to assets ratio x-0.20 -486.3%   
Return on assets %5.3-8.0 -65.9%  
Return on equity %8.4-364.5 -2.3%  
Return on capital %12.5-44.3 -28.2%  
Exports to sales %-37.322.8 -163.7%   
Imports to sales %-38.80.6 -6,517.7%   
Exports (fob) Rs m4,971785 632.9%   
Imports (cif) Rs m5,17821 25,196.3%   
Fx inflow Rs m4,971785 632.9%   
Fx outflow Rs m9,98026 38,003.8%   
Net fx Rs m-5,009759 -659.8%   
CASH FLOW
From Operations Rs m4,385-328 -1,336.7%  
From Investments Rs m-5,035-91 5,503.4%  
From Financial Activity Rs m899384 233.9%  
Net Cashflow Rs m250-35 -709.9%  

Share Holding

Indian Promoters % 61.0 24.6 247.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.8 21.9 22.0%  
FIIs % 2.9 7.5 38.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.0 75.4 51.7%  
Shareholders   54,751 35,184 155.6%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDIA GLYCOLS With:   PIDILITE INDUSTRIES    SRF    BALAJI AMINES    YASHO INDUSTRIES    GHCL    


More on INDIA GLYCOLS vs Sterling Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

INDIA GLYCOLS vs Sterling Biotech Share Price Performance

Period INDIA GLYCOLS Sterling Biotech
1-Day 2.05% -4.94%
1-Month -10.40% 6.94%
1-Year 59.33% -78.61%
3-Year CAGR 10.86% -46.43%
5-Year CAGR 40.06% -32.29%

* Compound Annual Growth Rate

Here are more details on the INDIA GLYCOLS share price and the Sterling Biotech share price.

Moving on to shareholding structures...

The promoters of INDIA GLYCOLS hold a 61.0% stake in the company. In case of Sterling Biotech the stake stands at 24.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDIA GLYCOLS and the shareholding pattern of Sterling Biotech.

Finally, a word on dividends...

In the most recent financial year, INDIA GLYCOLS paid a dividend of Rs 8.0 per share. This amounted to a Dividend Payout ratio of 14.3%.

Sterling Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of INDIA GLYCOLS, and the dividend history of Sterling Biotech.



Today's Market

Zomato to Enter Sensex | PVR Inox's Expansion Plan | Top Buzzing Stocks Todayeeq Zomato to Enter Sensex | PVR Inox's Expansion Plan | Top Buzzing Stocks Todayeeq(Pre-Open)

Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.